StockData
Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc. (OVID) stock

OVIDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/30
$2.26+0.04 (+1.80%)

Close on Nov 18, 2026Market cap $441.37MP/E –Yield –

Ovid Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Ovid Therapeutics's price to book ratio was 2.4× on Nov 11, 2026, against 2.8× a year earlier. Over the last 5 years it ranged from 0.3× to 2.8×, with a median of 1.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.4×−0.1
2025Dec 31, 20252.6×+1.7
2024Dec 31, 20240.9×−1.4
2023Dec 29, 20232.2×+1.3
2022Dec 30, 20220.9×−0.2
2021Dec 31, 20211.1×−1.2
2020Dec 31, 20202.3×−2.9
2019Dec 31, 20195.2×+4.0
2018Dec 31, 20181.2×−1.4
2017Dec 29, 20172.6×–

More Ovid Therapeutics figures

See a number that looks wrong?